This is read by an automated voice. Please report any issues or inconsistencies here. The American Cancer Society’s 2026 Cancer Statistics report, released Tuesday, marks a major milestone for U.S.

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

The American Cancer Society released its annual statistics report that shows significant progress in cancer survival rates ...

CLEVELAND, Ohio — Seven in 10 people now survive their cancer five years or longer, up from only half in the mid-1970s, according to a new report from the American Cancer Society. The five-year ...

Routine cancer screenings, improved treatments, and less smoking are the main reasons why 7 in 10 cancer patients are reaching the 5-year survival milestone, a new report shows. Almost 70 percent of ...

Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...

A record 70% of cancer patients are living five years past their diagnosis, according to a report released Tuesday by the American Cancer Society. The annual analysis of cancer statistics says early ...

The American Cancer Society reports that the five-year relative cancer survival rate for all cancers combined hit 70% for people diagnosed between 2016-2021 in the United States. "When we see such ...

More people are surviving cancer than ever before, new data from the American Cancer Society shows. Seventy percent of people diagnosed with cancer now live at least another five years, up from about ...

The five-year cancer survival rate has reached 70%, driven by treatment advances, reduced smoking, and early detection, yet lung cancer remains the leading cause of cancer deaths. Disparities in ...

Jan 22 (Reuters) - Eli Lilly and Co's stomach cancer drug ramucirumab met its primary goal of improving overall survival in a late stage-study, extending the lives of patients for more than a month ...